Annika Gutsche
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cold urticaria with negative standard cold stimulation testing: Results from the COLD-CE study.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 22, 2026
Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.
Journal: Allergy
Published: April 02, 2026
A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified.
Journal: Clinical and translational allergy
Published: December 16, 2025
Classification of angioedema types using decision tree modeling.
Journal: Frontiers in immunology
Published: September 12, 2025
Observations on quality of life and disease control in patients with hereditary angioedema.
Journal: Skin health and disease
Published: June 23, 2025
Development and Reliability Assessment of an Artificial Intelligence-Driven Urticaria Support (AIDUS) Chatbot.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 19, 2025
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
Journal: Clinical and translational allergy
Published: March 04, 2025
Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients.
Journal: Clinical and translational allergy
Published: October 23, 2024
Assessing the reliability of the FricTest® 4.0 for diagnosing symptomatic dermographism.
Journal: Clinical and translational allergy
Published: October 07, 2024
Development and Validation of a Disease Severity Index for Patients With Cold Urticaria.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 11, 2024
Addictive behavior is not a comorbidity of chronic spontaneous urticaria.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: July 04, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center.
Journal: Frontiers in immunology
Published: March 22, 2024
Last Updated: 09/26/2026